<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Annexin V is a human <z:chebi fb="0" ids="16247">phospholipid</z:chebi> binding protein (M(r) 36,000) that binds with high affinity to activated platelets in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the biodistribution and <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> binding of annexin V in rabbit and swine models of fully occlusive arterial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> formed 1-2 h prior to injection of annexin V </plain></SENT>
<SENT sid="2" pm="."><plain>Iodinated annexin V was cleared from blood in a rapid early phase (t1/2 = 6.4 min, 76% of radioactivity) and a slower late phase (t1/2 = 71 min, 24% of radioactivity) </plain></SENT>
<SENT sid="3" pm="."><plain>Organ uptake was highest in the kidney and spleen and lowest in heart and skeletal muscle </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e>/blood uptake ratios were (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>): 6.39 +/- 1.80 for rabbit iliac artery, 6.97 +/- 1.45 for swine carotid artery, and 7.68 +/- 1.70 for swine femoral artery (<z:hpo ids='HP_0000001'>all</z:hpo> p values &lt; 0.01 versus control artery); a control protein, ovalbumin, showed an uptake ratio of 0.59 +/- 0.08 in swine femoral artery <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate that annexin V is useful as an agent for selective targeting of platelet-containing <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
</text></document>